Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0000875320-25-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2025-02-26 | VRTX | ALTSHULER DAVID | EVP, CSO | F - Tax | $479.61 | -5,954 | 34.2K | -15% | -$2.86M | |
| 2025-02-28 | 2025-02-27 | VRTX | ALTSHULER DAVID | EVP, CSO | S - Sale | $480.00 | -1,272 | 33.0K | -4% | -$610.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | F | D | 5,954 | $479.61 | 34,246 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-27 | S | D | 1,272 | $480.00 | 32,974 | D | — | — |